Although it is recognized that human immunodeficiency virus (HIV) env genes exhibit a high degree of variability, little is known about the molecular heterogeneity of gp 120-specific antibodies in infected individuals. As a first step to approach this issue, we investigated the idiotypic relatedness of anti-gpl20 antibodies present in the serum of HIV-infected individuals. Idiotypic determinants (idiotopes) are fingerprints of the variable region of the antibody molecule and, as such, they represent unique probes with which to explore the diversity of the immune response. We isolated IgG anti-gp120 antibodies from the serum ofa seropositive asymptomatic individual by affinity chromatography. The purified antibodies were shown to bind gpl20 and gpl60 by ELISA, Western blotting and radio-immunoprecipitation. They also recognized HIV-infected human T cells as detected by immunofluorescence. Anti-idiotypic reagents were generated against this gp 120 idiotype, and one of them was used to study anti-gp120 idiotypic diversity in a panel of 65 sera drawn from AIDS and AIDS-related complex patients, and from HIV seropositive asymptomatic individuals. Sixty normal human sera were used as negative controls. We found no evidence for common idiotopes on anti-gpl20 antibodies of unrelated individuals. In contrast, we also noticed that the idiotypic profile expressed sequentially at two different intervals in a persistently infected individual showed little variation. Finally, when the diversity of murine anti-gp 120 antibodies with a monoclonal antiidiotype was analysed, no evidence of cross-reactive idiotopes in the murine system was found.
Introduction
It is becoming increasingly clear that the biology of human immunodeficiency virus (HIV) and the pathogenesis of AIDS are extraordinarily complex. Central to this complexity is the propensity of this retrovirus for genetic variation. Early studies showed that independent isolates of HIV-I exhibit a high degree of genetic heterogeneity. Subsequent molecular cloning and characterization of several HIV-1 isolates from different parts of the world revealed that nucleotide and predicted amino acid sequences of the outer envelope vary up to 18 and 33 %, respectively, and that the extent of variability in other genes among different HIV isolates ranges between 1 and 8% (Willey et al., 1986; Devare et al., 1986) . Studies of viruses isolated sequentially from persistently infected individuals at different intervals, and also of viruses isolated from blood donors and recipients, confirmed this extensive genetic variability and showed that HIV undergoes rapid changes in vivo (Srinivasan et al., 1987; Fisher et al., 1988) . Although the molecular basis and biological consequences of this genotypic variation are poorly understood, it is believed that it plays an important role in the pathogenesis of the viral infection.
That the hypervariable envelope glycoprotein gp120 is exposed to the immune system raises the question of the degree of heterogeneity of the immune response developed by the infected host. Idiotypic determinants, or idiotopes, are present on the variable regions of the antibody molecule and, as such, they provide unique markers with which to investigate the relatedness of the antibody response (reviewed by Rajewsky & Takemori, 1983; Dreesman & Kennedy, 1985) . As a first step to define the diversity of the immune response to the gp 120 antigen, we investigated the idiotypic expression of antigp120 antibodies present in HIV-l-infected individuals.
Methods
Subjects. Serum samples were obtained from 65 HIV-l-infected individuals. These seropositive subjects were either asymptomatic, or exhibited clinical manifestations in the form of persistent generalized iymphadenopathy (PGL), AIDS-related complex (ARC) or AIDS. Sera were heat-inactivated for 1 h at 56 °C and then stored at -20 °C. Control sera were drawn from 60 normal blood donors through the 'Fondation Nationale de Transfusion Sanguine', Paris, France. These sera were also heat-treated. Individual ZAN was a 30-year-old male who had high titres of serum antibodies to gpl20, gp41 and gpl60. At the time of study, he did not exhibit any clinical manifestation of the disease.
Recombinant proteins and synthetic peptides. Samples of gp160 of the HIV-I BRU isolate, produced in an Escherichia coti expression vector system, were obtained from Drs M. Girard and M. Kaczoreck (Pasteur Vaccins, Val de Reuil, France) . Chinese hamster ovary ceils transfected with a truncated env gene from HIV-1 BH10 isolate IIIB was obtained from Dr P. Stephens (Cellteeh) through the MRC AIDSDirected Programme, Cambridge, U.K. (Dr H. Holmes). Full-length recombinant gp120 was purified from the supernatant of cultured cells, which secreted approximately 1 /.tg/ml of soluble gpl20, by affinity chromatography using a murine monoclonal antibody to soluble gp 120 (Boudet et al., 1991) . The PB-I antigen (Putney et al., 1986) encompassing amino acid positions 295 to 474 of gpl20 of HIV-1 isolate IIIB was provided by Dr S. Putney (Repligen, Cambridge, Mass., U.S.A.). Synthetic peptides, produced by Merrifield solid phase synthesis, were provided by the "Agence Nationale de Recherche sur le SIDA', Paris, France. They included peptides corresponding to the following amino acid positions of gpl20:252 to 272, 302 to 324, 449 to 464, 465 to 480 and 474 to 489.
Detection of antibodies to HIV. Four assays were used to detect anti-HIV antibodies in the test sera and immunoaffinity-isolated antibodies.
(i) Radioimmunoprecipitation assay (RIPA). This was carried out using extracts from labelled HIV-l-infected cells as described by Krust et al. (1988) . Briefly, proteins were metabolically labelled by culturing HIV-1-infected cells for 16 h at 37 °C in MEM devoid of L-methionine and serum, but supplemented with 200 mCi/ml L-[3SS]methionine (Amersham). Radiolabelled cell and viral lysates were diluted in RIPA buffer, and incubated with dilutions of test sera or purified antibodies. Protein A-Sepharose beads were added to each tube to facilitate precipitation of the antigen-antibody complexes. Pellets were collected and, after extensive washing, coprecipitated proteins were analysed by electrophoresis with 12% SDS-polyacrylamide gel and then revealed by autoradiography.
(ii) Western blot assay. Each serum sample was screened for anti-HIV-I antibodies with a commercial Western blot kit (New Lay-Blot I, Diagnostics Pasteur). The assay was carried out as recommended by the manufacturer, and the presence of three bands of reactivity with the major HIV-I envelope proteins was considered evidence for seropositivity.
(iii) Enzyme immunoassay. Sera were also tested for antibodies to envelope proteins by EL1SA (Boudet et al., 1992a) . Briefly, microtitre plates (Nunc) were coated with the soluble recombinant test antigen (gp160, gp 120 or PB-1) at 1 ~tg/ml in Tris-buffered saline p H 7.4 (TBS). Following incubation of dilutions of serum or purified immunoglobulin in the antigen-coated wells, bound antibodies were revealed by incubation with a 1 x 10 -3 dilution of an alkaline phosphatase-labelled goat anti-human IgG or IgM (Fc-specific) F(ab')2 fragment (Sigma). All dilutions were made in TBS containing 1% BSA (TBS-BSA) and 0.1% Tween 20. All steps described above were followed by three washings in PBS containing 0.1% Tween 20, and the plates were incubated for 90 min at 37 °C during each step. After the last washing step, 100 gl of an appropriate substrate for alkaline phosphatase (1 mg/ml p-nitrophenyl phosphate dissolved in 0.1 M-sodium carbonate buffer pH 9.2 containing 1 mM-MgCI2) was added and the plates were incubated at 37 °C for 45 min. An05 was recorded with a Dynatech multiscan.
(iv) Immunofluorescence. Anti-HIV-1 antibodies were detected by an indirect immunofluorescence assay. HIV-l-infected H9 cells were washed and air-dried on glass microscope slides and fixed in 50% methanol/50% acetone at room temperature. The slides were incubated with dilutions of the test sera or purified immunoglobulins for 30 min at 37°C in a humidified atmosphere. After washing, fluorescein isothiocyanate-conjugated goat anti-human Ig F(ab') 2 fragments were added and the cells were incubated for a further 45 rain. After a final wash and an Evans blue counterstain, the slides were examined under a Zeiss fluorescence microscope and the percentage of cells exhibiting specific immunofluorescence was determined.
lmmunoaBinity isolation of antibodies. An affinity column was prepared by immobilizing PB-I on CNBr-activated Sepharose-4B (Pharmacia) in 0.1 M-NaHCO3 pH 8.3 according to the manufacturer's recommendations. The amount of coupled protein was assessed by measuring the unreacted protein in the reaction supernatant. The load of bound protein was approximately 1 mg/ml of gel matrix. Unreacted sites of the gel were blocked by using 1 M-ethanolamine pH 8.0. The ammonium sulphate-precipitated immunoglobulin fraction of the positive serum from subject ZAN was added to the immobilized recombinant protein and the slurry was mixed gently overnight at 4 °C. The gel matrix was then poured into a column and washed extensively with PBS. Antibodies bound to the immobilized antigen were eluted with 3 M-KSCN, dialysed against PBS and concentrated.
Generation of anti-idiotypic antibodies.
Anti-idiotype antisera to affinity-purified human ZAN IgG anti-PBl antibodies (Abl) were raised in three rabbits (A, B and D) by intramuscular injections in adjuvant at 3 week intervals, first in Freund's complete and then in Freund's incomplete adjuvant (Difco). For the first injection, 50 ~tg of antibody was used. This was increased to 100 [.tg for the six injections which followed, and blood samples were collected at regular intervals (Zouali et al., 1984a, b) . Sera of hyperimmunized rabbits were passed repeatedly over affinity columns of immunoglobulins isolated from a pool of human sera which lacked detectable anti-HIV antibody activity. All the experiments described herein used serum from rabbit A which exhibited the strongest anti-idiotypic response.
Detection ofidiotype-anti-idiotype interaction. ELISA was used (Corre et al., 1991) . Microtitre plates were coated with the ZAN Abl or with control normal human immunoglobulins at 1 ~tg/ml. After saturation of the unoccupied sites of the polystyrene microtitre wells with PBS-BSA, wells were incubated with various dilutions of the test rabbit antiidiotype. After washing, bound antibodies were detected with a 10 -3 dilution of an alkaline phosphatase-labelled goat anti-rabbit immunoglobulin F(ab')2 fragment (Sigma) which had been adsorbed previously on human serum proteins. After incubation, the plates were processed as described above.
Competitive inhibition of the idiotype binding to the nominal antigen by the anti-idiotype.
The ZAN idiotype at a concentration that gave 60% of maximal binding to gpl60 antigen was mixed with appropriate dilutions of the rabbit anti-idiotype, incubated at 37 °C for 90 min, and added to plates that had been coated with gp160. After incubation and appropriate washing, bound antibodies were revealed by the addition of a 10 -3 dilution of alkaline phosphatase-labelled goat anti-human immunoglobulins. Binding of each dilution of rabbit anti-idiotype competitor was calculated relative to a set of wells receiving no competitor. Determinations were performed in duplicate and binding of each dilution of competitor was expressed relative to a set of wells receiving no competitor according to the formula: inhibition (%) = 100 x [(1-A40s in the presence of competitor)/A4os in the absence of competitor].
Competitive immunoassay for the presence of the ZAN idiotype in human sera. Equal volumes of the rabbit anti-idiotype, at a concentration that achieved 60 % of maximal binding to the nominal idiotype, and various dilutions of the competitors (homologous affinity-purified ZAN idiotype, homologous ZAN serum and test sera from unrelated subjects) were mixed and preincubated for 90 min at 37 °C. One-hundred ttl of the mixture was then transferred to polystyrene microtitre plates that were precoated with the ZAN idiotype. After a further incubation and washings, the labelled anti-rabbit conjugate was added and the reaction continued as described above.
Assays for idiotypic expression in murine anti-gpl20 antibodies.
Immunization of mice, generation of the monoclonal anti-gpl20 and anti-idiotypic antibodies and the various immunoassays have been described elsewhere (Boudet et al., 1991 (Boudet et al., , 1992b .
Assay for virus neutralization. Serial dilutions of test antibodies were incubated with virus supernatant (105 d.p.m.) for 1 h at 37 °C in fiatbottomed microtitre plates. CD4-positive cells (104; CEM cell line) were then added and the ceils were cultured for several days in an incubator with a 5~ CO2 atmosphere. Residual viral infectivity was determined on days 6 and 13 by measurement of reverse transcriptase production as described by Schwartz et al. (1988) . 
Results
The serum of an asymptomatic HIV-l-seropositive individual, designated ZAN, was selected for this study. (Javaherian et al., 1989) , our data are consistent with the conclusion that one population of ZAN neutralizing antibodies is directed to the major neutralizing epitope of gpl20. Total immunoglobulins were isolated from ZAN serum by ammonium sulphate precipitation. From this immunoglobulin fraction, gpl20-specific antibodies were afffinity-purified on a column of the recombinant protein PB-1 immobilized on Sepharose beads. This molecule was used as a substitute for gp 120 because large quantities of gpl20 were not available at the time we performed these experiments. The purified IgG exhibited the following properties: (i) it reacted with recombinant gpl60 and gpl20 (data not shown) proteins as shown by ELISA; (ii) it bound to viral gpl20 and gpl60 as shown by a radioimmunoprecipitation assay (Fig. 1 ) and Western blotting; (iii) it recognized HIV-l-infected H9 cells, but not control cells, as shown by indirect immunofluorescence (Fig. 2) . Therefore, it is referred to as ZAN anti-gpl20 antibody, or Abl. Rabbits were immunized against Abl and, after several boosts, rabbit A exhibited the highest response to the immunogen. This immune rabbit serum was rendered idiotype-specific by extensive adsorptions on a pool of normal human immunoglobulins. The adsorbed material reacted with ZAN anti-gpl20 antibodies by ELISA, and failed to recognize normal human immunoglobulins, or ZAN immunoglobulins depleted of anti-gpl20 activity by passage through an affinity column (Fig. 3) .
To see whether the anti-idiotype recognized paratoperelated idiotypic determinants, we tested its inhibitory 3 . Binding of the rabbit anti-idiotype to its homologous ZAN antigpl20 human idiotype. Microtitre plates were coated with 1 ~tg/ml of ZAN idiotype (ll), ZAN immunoglobulins devoid of anti-gpl20 activity (O) or control normal human immunoglobulins (13). The rabbit anti-idiotype diluted in PBS containing 1% BSA was added, and bound antibodies were revealed by the addition of an enzyme-labelled antirabbit immunoglobulin reagent as indicated in Methods. Fig. 2 . Binding of affinity-purified ZAN anti-gpl20 antibodies to HIV-infected cells. H9 ceils were infected with HIV-1 isolate IIIB and then fixed onto glass microscope slides. Affinity-purified Z A N antigpl20 antibodies at a concentration of 10 ~g/ml (b) or control human immunoglobulins (a) were added and, after incubation and washing, fluorescein isothiocyanate-conjugated goat anti-human Ig F(ab')2 fragments were added. Cell preparations were examined under a fluorescence microscope. ZAN Abl (100 gl, 2.5 gg/ml) was incubated with various dilutions of rabbit anti-idiotypic antiserum (O) or a control normal rabbit preimmune serum (©). One-hundred ~tl of the mixture was then transferred to gpl60-coated wells (l ~tg/ml) and bound antibodies were detected by the addition of an alkaline phosphatase-tabelled antihuman immunoglobulin conjugate.
capacity on the interaction of the Abl with its nominal antigen. As shown in Fig. 4 , the anti-idiotype was capable of partially blocking the antigen-antibody reaction. This blocking activity was idiotype-specific; for example, binding of human anti-tetanus toxoid antibodies, of a similar purity and at an equivalent concentration, to tetanus toxoid-coated wells was not affected by the anti-idiotype antibody. These experiments show that the rabbit anti-idiotype used in this study is directed towards idiotopes near, or within, the binding site of ZAN anti-gpl20 antibodies, but not idiotopes of antibodies of another specificity (see Discussion).
To determine the presence of shared idiotopes on antigpl20 antibodies of unrelated seropositive subjects, we designed a sensitive, competitive immunoassay. In this assay, the test serum is examined for its ability to inhibit the binding of the anti-idiotype to its homologous idiotype immobilized on the solid phase. At a dilution of 1/12800, ZAN serum inhibited the idiotype-anti-idiotype interaction by 80% (Fig. 5) . Sera from unrelated HIV-1 seropositive individuals and from control individuals were diluted 1/100 and 1/500 and tested by this competitive assay. Under these experimental conditions, only the homologous ZAN serum gave a significant inhibition of the idiotype-anti-idiotype interaction. The test sera gave less than 15% inhibition of ZAN idiotype binding to the anti-idiotype. These data indicate that anti-gpl20 antibodies present in the test sera do not express the ZAN idiotype. The viral strains infecting ZAN and the other subjects investigated have not been isolated. However, in testing the antibody reactivity of the test sera with V3 synthetic peptides corresponding to 12 HIV-1 isolates, we noted that the binding profile of ZAN serum is essentially similar to that of the panel tested (Boudet et al., 1992a) . This may indicate that there is some degree of relatedness among the HIV infections in the individuals concerned.
From these results we undertook a retrospective temporal analysis of ZAN idiotype expression in ZAN serum. A serum sample drawn from this subject 11 months before collection of the serum sample used to generate the anti-idiotype was analysed. We found that the ZAN idiotype was also present in this early serum sample.
We then extended this idiotypic analysis to monoclonal murine antibodies. An anti-gpl20 MAb, F19-48-3, was produced in BALB/c mice (Boudet et al., 1991) . Mice were immunized against this antibody and several anti-idiotypes were produced (Boudet et al., 1992 b) . One of them, F23-57-1, an IgG2a ic, was used to test the idiotypic diversity of panels of nine anti-gpl20 routine MAbs, 14 sera of immune mice and 20 sera from seropositive individuals. In line with the results obtained above, no recurrent expression of the F19-48-3 idiotype could be detected in any of these antibody responses.
Discussion
Initially considered unique to antibody molecules of a given individual (Oudin & Michel, 1963; Kunkel et al., 1963) , identical idiotopes have since been observed in the immunoglobulins of unrelated subjects (reviewed by Rajewsky & Takemori, 1983; Dreesman & Kennedy 1985) . Characterization of the idiotypic determinants present on antibody variable regions provides a useful approach for investigating the diversity of the humoral immune response to a given pathogen. We have applied this analysis to anti-gpl20 antibodies present in the serum of unrelated anti-HIV seropositive individuals.
The anti-idiotypic antibody used in this study was raised against anti-gpl20 antibodies isolated from the serum of a HIV-1 seropositive individual designated ZAN. Although it reacted with ZAN afffinity-purified anti-gpl20 antibodies, it did not interact with ZAN antibodies devoid of anti-gpl20 activity or with normal human immunoglobulins. In addition, the anti-idiotype was capable of partially inhibiting the binding of the affinity-purified homologous ZAN idiotype to gpl60. These results indicate that this anti-idiotypic reagent did not recognize isotopes or allotopes within the variable or constant regions of ZAN antibodies. Rather it recognized idiotopes associated with the variable region of ZAN anti-gpl20 antibodies.
We wish to emphasize that the purpose of this work was to examine the idiotypic diversity of the anti-gpl20 human antibody response of a sizeable study group. We therefore chose a 180 amino acid length of a recombinant protein of gp 120 which includes the principal neutralizing domain of HIV. Despite the recombinant nature of this antigen, the purified antibodies used to raise the anti-idiotype recognized native epitopes present on HIVinfected cells, as detected by immunofluorescence. It is therefore reasonable to conclude that the anti-idiotype generated against this ZAN IgG Abl could be used to analyse a sizeable proportion of the human anti-gpl20 antibody response. However, the approach we have used could not allow probing of antibodies recognizing conformational and discontinuous epitopes or linear motifs not included in the PB-I subfragment.
It could be argued that the use of only one antiidiotypic reagent may have resulted in underestimation of the extent of the idiotypic recurrence. This, however, seems unlikely for the following reasons. First, upon experimental idiotypic immunization, rabbits generally produce a strong anti-idiotypic response to recurrent dominant idiotopes. For example, four rabbit antisera raised against two different human IgG anti-hepatitis B virus surface antigen (HBs) preparations detected a common determinant shared by three anti-HBs preparations, and anti-HBs-positive sera obtained from six haemophiliac patients. This anti-HBs idiotype was not found on IgG isolated from sera negative for anti-HBs (Kennedy & Dreesman, 1983) . Similar data have been reported in other cross-reactive idiotypic systems (Zouali et al., 1984a, b) . Second, in experiments related to those reported herein another rabbit (B) immunized against ZAN anti-gpl20 antibodies produced paratope-related internal image anti-idiotypes with functional binding activity to CD4, the natural receptor of HIV (Corre et al., 1991) . Finally, in studying the diversity of murine antigpl20 antibodies with a monoclonal anti-idiotype, we could not detect the presence of cross-reactive idiotopes. This, together with the fact that, with one exception (Miiller et al., 1991) , there have been no reports of the presence of common idiotopes on human anti-gpl20 antibodies, supports the conclusion that the ZAN idiotype reported herein is representative of the idiotypes expressed by human antibodies to gpl20.
Whereas the human immune response to HBs is idiotypically restricted (Kennedy & Dreesman, 1983) , we found that anti-gpl20 antibodies of HIV-l-infected individuals express unrelated idiotypic determinants. These idiotypic features of the humoral immune responses against the hepatitis B virus (HBV) and HIV, which are associated with 'natural' infection of man, may reflect the genomic heterogeneity of HBV and HIV. HBV exhibits little tendency to genotypic heterogeneity, and only nine subtypes with amino acid sequence variation of the major polypeptide of the envelope are known (Tiollais & Wain-Hobson, 1984) . In contrast, the propensity of the HIV env genome to vary is extremely high, and several hundred HIV isolates have been described (LaRosa et al., 1990) . Therefore, it may not be too surprising that the diversity of the repertoire developed by the immune system to respond to this highly varying envelope antigen is high also.
Most pertinent to our results is the finding that common idiotopes are associated with antibodies to the p24 gag core protein of HIV (Morrow et al., 1990) . However, in this latter study a murine monoclonal antibody to p24 derived from an experimentally immunized mouse was used to generate the rabbit antiidiotype. In contrast, we have made use of a human antibody to gpl20 present in the serum of an HIV-1 seropositive individual. One possibility is that idiotypic repertoires are expressed following experimental immunization of animals against HIV which are distinct from 'natural' infection of humans. On the other hand, in contrast to the env antigens, the gag antigens are relatively conserved among HIV isolates and, in this respect, are analogous to HBs. This conservation may account for the observed recurrence of the idiotypic response to HIV core proteins (Morrow et al., 1990) . In another study, anti-idiotypes raised against an Ig fraction derived from pooled plasma of 17 seropositive donors, and against an anti-gp41 antibody, reacted with shared idiotypes of anti-HIV antibodies, including antigp41 and anti-p24 antibodies (Miiller et al., 1991) . Further studies are required to probe the idiQtypic repertoire expressed in response to the various HIV antigens.
A key feature of HIV is its extensive genetic variation. The rate of evolution of HIV is estimated to be at least 10 -3 nucleotide substitutions per site per year for the env gene, 106-fold greater than for most eukaryotic genomes (Hahn et al., 1986 ). This diversity is characterized by a wide variety of changes, including transitions, transversions, insertions and deletions (Hahn et al., 1986) . Therefore, it is not unexpected that the infected host develops an antibody response targeted to the diverse invading HIV isolates and bearing unique unrelated idiotypic determinants.
This remarkably high rate of viral evolution is thought to determine, in part, resistance to immunological attack. That viruses isolated from single individuals at a given time appear to consist of a population of virus isolates that slightly differ among themselves (Alizon et al., 1986; Hahn et al., 19'86) illustrates the propensity of HIV to mutate and indicates variation changes in prevalent strains. To see whether this viral heterogeneity is associated with a temporal idiotypic variability of the antibody response, we analysed the expression of the ZAN idiotype for change over time, but found no trend. This stability over time could reflect a state of viral suppression of replication and subsequently mutation in asymptomatic subjects. It may also imply that the idiotypic profile evolves more slowly than the rate of viral variability. Alternatively, it could indicate that the idiotype response to an HIV strain was prevalent early in the course of infection of subject ZAN and subsequently became dominant through selective immune pressure. However, these are merely assumptions because we have not determined the extent of HIV genomic changes in subject ZAN.
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